Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The peritoneal membrane transport system represents the physiological mechanism responsible for fluid and waste exchange during peritoneal dialysis (PD). This system is conceptualized by the 'Three-Pore Model,' which identifies three distinct pathways for transport across the peritoneal capillary endothelium: ultra-small pores (Aquaporin-1), small pores (intercellular clefts), and large pores (venular gaps) [1, 2]. Aquaporin-1 (AQP1) is the primary molecular target for water transport, facilitating approximately 50% of ultrafiltration driven by crystalloid osmotic gradients like glucose [3, 4]. Small pores allow for the diffusion of small solutes like urea and creatinine, while large pores permit the passage of macromolecules such as albumin [2]. Chronic exposure to bioincompatible dialysis fluids can lead to structural remodeling, including peritoneal fibrosis and neoangiogenesis, which results in ultrafiltration failure—a major cause of PD technique failure [1, 3]. Therapeutic interventions focus on using osmotic agents like icodextrin to bypass AQP1-mediated transport or experimental agents like SGLT2 inhibitors to preserve membrane integrity [2, 6]. Citations: [1] Rippe B. (1993) PMID: 8395256; [2] Devuyst O, et al. (2002) PMID: 12138152; [3] Morelle J, et al. (2015) PMID: 26224789; [4] Ni J, et al. (2001) PMID: 11298774; [6] Martus G, et al. (2021) PMID: 33479017.
Generation of crystalloid or colloid osmotic gradients to drive water and solute flux through specific pore populations, including Aquaporin-1 and intercellular clefts [1, 2].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peritoneal membrane transport system.